DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma.
第一作者:
M,Lazzarino
第一单位:
Division of Hematology, IRCCS Policlinico S Matteo, University of Pavia, Italy.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗原, CD34(Antigens, CD34);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);血细胞计数(Blood Cell Count);骨髓净化(Bone Marrow Purging);顺铂(Cisplatin);环磷酰胺(Cyclophosphamide);地塞米松(Dexamethasone);依托泊甙(Etoposide);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);造血干细胞动员(Hematopoietic Stem Cell Mobilization);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);治疗结果(Treatment Outcome)
DOI
10.1038/sj.bmt.1703240
PMID
11781643
发布时间
2019-12-10
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



